Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma

International Journal of Molecular Medicine

Volumn 30, Issue 3, 2012, Pages 465-472

  Chen, Zhouxun ^a   Liu, Naxin ^a   Zhu, Guanbao ^a   Dralle, Henning ^b   Hoang Vu, Cuong ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

FTC 133 cell line; Inhibitor of apoptosis; Prognostic factor; Small interfering RNA; Survivin; Thyroid carcinoma

Indexed keywords

BETA ACTIN; FLUORESCEIN; MESSENGER RNA; SMALL INTERFERING RNA; SURVIVIN;

ADULT; AGE; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISTANT METASTASIS; FEMALE; GENDER; GENE TARGETING; GOITER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADULT; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GOITER; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RNA INTERFERENCE; RNA, MESSENGER; THYROID NEOPLASMS;

EID: 84865170083     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1046     Document Type: Article

References (29)

1. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
2. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
3. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
4. Sachs L and Loterm J: Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82: 15-21, 1993. (Pubitemid 23188740)
5. Yang E and Korsmeyer SJ: Molecular thanatopsis: a discourse on the bcl-2 family and cell death. Blood 88: 1456-1462, 1996.
6. Crook NE, Clem RJ and Miller LK: An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 67: 2168-2174, 1993. (Pubitemid 23088392)
7. Ambrosini G, Adida C and Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921, 1997. (Pubitemid 27353455)
8. Li F and Altieri DC: The cancer anti-apoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res 59: 3143-3151, 1999. (Pubitemid 29316014)
9. Li F and Altieri DC: Transcriptional analysis of human survivin gene expression. Biochem J 344: 305-311, 1999. (Pubitemid 30011584)
10. Takahashi R, Deveraux QL, Tamm I, Welsh K, Assa-Munt N, Salvesen GS and Reed JC: A single BIR domain of XIAP suffi-cient for inhibiting caspases. J Biol Chem 273: 7787-7790, 1998. (Pubitemid 28168819)
11. Lu CD, Altieri DC and Tanigawa N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58: 1808-1812, 1998. (Pubitemid 28217451)
12. Kawasaki H, Altieri DC, Lu C-D, Toyoda M, Tenjo T and Tanigawa N: Inhibition of apoptosis by survivin predict shorter survival rates in colorectal cancer. Cancer Res 58: 5071-5074, 1998. (Pubitemid 28521163)
13. Monzó M, Rosell R, Felip E, et al: A Novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17: 2100-2104, 1999. (Pubitemid 29318841)
14. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134, 2000. (Pubitemid 30064984)
15. Liggins C, Orlicky DJ, Bloomquist LA and Gianani R: Developmentally regulated expression of survivin in human pancreatic islets. Pediatr Dev Pathol 6: 392-397, 2003. (Pubitemid 37323431)
16. Krajewska M, Krajewski S, Banares S, et al: Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 9: 4914-4925, 2003. (Pubitemid 37323298)
17. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J and Altieri DC: Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 152: 43-49, 1998. (Pubitemid 28028045)
18. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584, 1998. (Pubitemid 28563719)
19. Yang E and Korsmeyer SJ: Molecular thanatosis: a discourse on the BCL2 family and cell death. Blood 88: 386-401, 1996. (Pubitemid 26240369)
20. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387: 773-776, 1997.
21. Wei Y, ZhaoX, Kariya Y, Teshigawara K and Uchida A: Inhibition of proliferation and induction of apoptosis by abrogation of heat-shock protein (HSP) expression in tumor cells. Cancer Immunol Immunother 40: 73-78, 1995.
22. Mairesse N, Horman S, Mosselmans R and Galand P: Antisense inhibition of the 27 kDa heat shock protein production affects growth rate and cytoskeletal organization in MCF-7 cells. Cell Biol Int 20: 205-212, 1996. (Pubitemid 26197512)
23. Randall G, Grakoui A and Rice CM: Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci USA 100: 235-240, 2003. (Pubitemid 36078058)
24. Yang G, Thompson JA, Fang B and Liu J: Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer. Oncogene 22: 5694-5701, 2003. (Pubitemid 37102706)
25. Ambrosini G, Adida C, Sirugo G and Altieri DC: Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273: 11177-11182, 1998. (Pubitemid 28204967)
26. Reed JC: Promise and problems of Bcl-2 antisense therapy. J Natl Cancer Inst 89: 988-990, 1997.
27. Fei Q, Zhang H, Fu L, et al: Experimental cancer gene therapy by multiple anti-survivin hammerhead ribozymes. Acta Biochim Biophys Sin (Shangai) 40: 466-477, 2008. (Pubitemid 351847347)
28. Zheng WY, Kang YY, Li LF, Xu YX and Ma XY: Levels of effectiveness of gene therapies targeting survivin and its splice variants in human breast cancer cells. Drug Discov Ther 5: 293-298, 2011.
29. Yamanaka K, Nakata M, Kaneko N, et al: YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer. Int J Oncol 39: 569-575, 2011.